Evidence map›Paper›PMID 41975818›Full record

ArticleDiagnostics (Basel, Switzerland)2026

Corneal Toxicity of Mirvetuximab Soravtansine: Multimodal Imaging Features and Implications for Ophthalmologic Management.

Francesco De Dominicis, Andrea Giudiceandrea, Martina Cocuzza, Simone Bruzio, Romina Fasciani, Luigi Mosca, Chiara Giudiceandrea, Matteo Salgarello, Epifanio Giudiceandrea, Filippo Amore and 5 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Francesco De DominicisEye Clinic, Fondazione Policlinico Universitario A. Gemelli IRCCS, Largo A. Gemelli 8, 00168 Rome, Italy.ORCID 0009-0004-3089-7696
Andrea GiudiceandreaEye Clinic, Fondazione Policlinico Universitario A. Gemelli IRCCS, Largo A. Gemelli 8, 00168 Rome, Italy.
Martina CocuzzaEye Clinic, Fondazione Policlinico Universitario A. Gemelli IRCCS, Largo A. Gemelli 8, 00168 Rome, Italy.
Simone BruzioEye Clinic, Fondazione Policlinico Universitario A. Gemelli IRCCS, Largo A. Gemelli 8, 00168 Rome, Italy.ORCID 0009-0005-0255-8985
Romina FascianiEye Clinic, Fondazione Policlinico Universitario A. Gemelli IRCCS, Largo A. Gemelli 8, 00168 Rome, Italy.
Luigi MoscaEye Clinic, Fondazione Policlinico Universitario A. Gemelli IRCCS, Largo A. Gemelli 8, 00168 Rome, Italy.ORCID 0000-0003-4641-0841
Chiara GiudiceandreaUniversità Cattolica del Sacro Cuore, 00168 Rome, Italy.
Matteo SalgarelloUniversità Cattolica del Sacro Cuore, 00168 Rome, Italy.
Epifanio GiudiceandreaSan Paolo Hospital, University of Milan, 20122 Milan, Italy.
Filippo AmoreIAPB Italia ETS Foundation, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.ORCID 0000-0002-2461-8951
Stanislao RizzoEye Clinic, Fondazione Policlinico Universitario A. Gemelli IRCCS, Largo A. Gemelli 8, 00168 Rome, Italy.
Maria Vittoria CarboneWoman, Child and Public Health Department, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.
Vanda SalutariUniversità Cattolica del Sacro Cuore, 00168 Rome, Italy.
Anna FagottiUniversità Cattolica del Sacro Cuore, 00168 Rome, Italy.ORCID 0000-0001-5579-335X
Tommaso SalgarelloEye Clinic, Fondazione Policlinico Universitario A. Gemelli IRCCS, Largo A. Gemelli 8, 00168 Rome, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antibody–drug conjugatescorneal toxicitymirvetuximab soravtansineocular adverse events

Identifiers

PMID41975818
PMCPMC13073349

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.